United Therapeutics Corporation UTHR announced that the FDA has approved the new drug application for the dry powder inhalation (DPI) formulation for its key pulmonary arterial hypertension (PAH) drug ...
Most dry powder inhalers (DPI) operate with pre-metered doses of drug formulation held in a capsule or blister pack. The ability of dosator systems to deliver the required accuracy at high throughput ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback